Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance
Year: 2015
Type: article
Abstract: Leukemogenesis occurs under hypoxic conditions within the bone marrow (BM). Knockdown of key mediators of cellular responses to hypoxia with shRNA, namely hypoxia-inducible factor-1α (HIF-1α) or HIF-2α, in human acute myeloid leukemia (AML) samples results in their apoptosis and inability to engraft, implicating HIF-1α or HIF-2α as therapeutic targets. However, genetic deletion of Hif-1α has no effect on mouse AML maintenance and may accelerate disease development. Here, we report the impact of conditional genetic deletion of Hif-2α or both Hif-1α and Hif-2α at different stages of leukemogenesis in mice. Deletion of Hif-2α accelerates development of leukemic stem cells (LSCs) and shortens AML latency initiated by Mll-AF9 and its downstream effectors Meis1 and Hoxa9. Notably, the accelerated initiation of AML caused by Hif-2α deletion is further potentiated by Hif-1α codeletion. However, established LSCs lacking Hif-2α or both Hif-1α and Hif-2α propagate AML with the same latency as wild-type LSCs. Furthermore, pharmacological inhibition of the HIF pathway or HIF-2α knockout using the lentiviral CRISPR-Cas9 system in human established leukemic cells with MLL-AF9 translocation have no impact on their functions. We therefore conclude that although Hif-1α and Hif-2α synergize to suppress the development of AML, they are not required for LSC maintenance.
DOI: 10.1084/jem.20150452
Authors: Milica Vukovic, Amelie V. Guitart, Catarina Sepulveda, Arnaud Villacreces, Eoghan O'Duibhir, Theano I. Panagopoulou, Alasdair Ivens, Juan Menendez-Gonzalez, Juan Manuel Iglesias, Lewis Allen, Fokion Glykofrydis, Chithra Subramani, Alejandro Armesilla-Diaz, Annemarie E.M. Post, Katrin Schaak, Deniz Gezer, Chi Wai Eric So, Tessa L. Holyoake, Andrew Wood, Dónal O'Carroll, Peter J. Ratcliffe, Kamil R. Kranc
Institutions: MRC Centre for Regenerative Medicine, University of Edinburgh, Centre for Immunity, Infection and Evolution, Universitätsklinikum Aachen, University of Glasgow, King's College London, Institute of Genetics and Cancer, European Molecular Biology Laboratory, University of Oxford, Edinburgh Cancer Research
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2215824313
